Form 4: Sensata EVP Schwabe Granted 21,683 Restricted Shares
Executive Compensation Grant
Sensata Technologies Holding plc's EVP, Markus Schwabe, received a grant of 21,683 unvested restricted ordinary shares as part of the company's 2021 Equity Incentive Plan.
Summary
- Markus Schwabe, Executive Vice President of Auto & Aftermarket at Sensata Technologies Holding plc, was granted 21,683 Ordinary Shares.
- The shares have a par value of EUR 0.01 per share and were granted at a price of $0.
- This grant was made pursuant to the Sensata Technologies Holding plc 2021 Equity Incentive Plan.
- The granted securities are unvested restricted shares.
- The restricted securities will vest over three years, with one-third vesting per year, commencing on February 1, 2027.
- Vesting is contingent upon Mr. Schwabe's continued service to the company.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a slightly positive event, as it represents a standard executive compensation practice that aligns management's interests with long-term shareholder value, without indicating any immediate operational or financial changes.
Positives
- The grant of restricted shares aligns the executive's long-term interests with those of shareholders, incentivizing sustained performance.
- This is a standard component of executive compensation, indicating ongoing commitment to retaining key management.
Future Outlook
The restricted shares are scheduled to vest over a three-year period, beginning February 1, 2027, subject to the executive's continued employment, indicating a long-term retention strategy for key management.
Management Comments
- The grant was made 'pursuant to the Sensata Technologies Holding plc 2021 Equity Incentive Plan'.
Industry Context
StockSavvy.ai notes that the grant of restricted stock units to executives is a common practice across industries, particularly in technology and manufacturing sectors, to align management incentives with long-term shareholder value creation and to retain key talent.
Comparison to Industry Standards
- This type of equity grant, with a multi-year vesting schedule, is consistent with executive compensation practices observed at comparable industrial technology companies such as TE Connectivity Ltd. (TEL) and Amphenol Corporation (APH), which frequently use restricted stock to incentivize long-term performance and retention.
Stakeholder Impact
- Shareholders: The grant aligns the interests of a key executive with long-term shareholder value creation, potentially leading to more sustained performance.
- Employees: This grant is specific to a senior executive and does not directly impact the broader employee base, though it reflects the company's overall compensation philosophy.
Next Steps
- The restricted shares will vest in one-third increments annually, starting February 1, 2027, contingent on continued service.
Key Dates
| Date | Description |
|---|---|
| 02/01/2026 | Date of grant of 21,683 Ordinary Shares to Markus Schwabe. |
| 02/03/2026 | Date the Statement of Changes in Beneficial Ownership (Form 4) was signed. |
| 02/01/2027 | Date when the first one-third of the restricted securities begin to vest. |
Recommendation
holdThis Form 4 filing details a routine executive compensation grant and does not provide sufficient new information to alter the fundamental investment thesis for Sensata Technologies Holding plc. While the grant aligns executive interests, it is a standard event and typically does not warrant a change in investment recommendation based solely on this disclosure.
Keywords
Sensata Technologies, ST, Markus Schwabe, Executive Compensation, Restricted Stock Units, Equity Grant, Form 4, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.